Filed: 8/14/2026ACC: 0001856083-26-000004
📋 What this filing means
DEEP TRACK CAPITAL, LP filed this quarterly 13F‑HR report disclosing 66 equity positions with a total reported market value of $6.87B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
66
Positions
$6.87B
Total AUM (reported)
264.93M
Total Shares
Allocation by class
COM$4.37B63.6%
SPONSORED ADS$664.10M9.7%
COM SHS$479.96M7.0%
COM NEW$428.30M6.2%
COMMON STOCK$261.30M3.8%
SHS$209.58M3.1%
CL A$171.64M2.5%
Portfolio Concentration
Top 3$1.12B16.4%
4–10$1.64B23.9%
11–25$2.40B34.9%
Rest$1.71B24.8%
Top 3 weight
16.4%
Top 10 weight
40.3%
Voting Authority Distribution
Total shares with voting rights: 264.93M
Sole
Full voting authority
264.93M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole66
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings66
Rows:
GUARDANT HEALTH INC
SOLEShares3.39M
TypeSH
Market value$509.10M
7.41%
Sole
3.39M
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares9.34M
TypeSH
Market value$359.91M
5.24%
Sole
9.34M
Shared
0.00
None
0.00
STRUCTURE THERAPEUTICS INC
SOLEShares4.74M
TypeSH
Market value$254.40M
3.70%
Sole
4.74M
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares4.30M
TypeSH
Market value$249.96M
3.64%
Sole
4.30M
Shared
0.00
None
0.00
ALNYLAM PHARMACEUTICALS INC
SOLEShares825K
TypeSH
Market value$248.35M
3.61%
Sole
825K
Shared
0.00
None
0.00
VERADERMICS INC
SOLEShares2M
TypeSH
Market value$245.88M
3.58%
Sole
2M
Shared
0.00
None
0.00
GENMAB A/S
SOLEShares8.65M
TypeSH
Market value$237.62M
3.46%
Sole
8.65M
Shared
0.00
None
0.00
TARSUS PHARMACEUTICALS INC
SOLEShares3.67M
TypeSH
Market value$230.79M
3.36%
Sole
3.67M
Shared
0.00
None
0.00
NUVALENT INC
SOLEShares1.78M
TypeSH
Market value$220.24M
3.21%
Sole
1.78M
Shared
0.00
None
0.00
ALKERMES PLC
SOLEShares4M
TypeSH
Market value$209.58M
3.05%
Sole
4M
Shared
0.00
None
0.00
OCULAR THERAPEUTIX INC
SOLEShares19.69M
TypeSH
Market value$193.32M
2.81%
Sole
19.69M
Shared
0.00
None
0.00
BIOMARIN PHARMACEUTICAL INC
SOLEShares3.31M
TypeSH
Market value$189.25M
2.75%
Sole
3.31M
Shared
0.00
None
0.00
NURIX THERAPEUTICS INC
SOLEShares7.74M
TypeSH
Market value$187.69M
2.73%
Sole
7.74M
Shared
0.00
None
0.00
ORUKA THERAPEUTICS INC
SOLEShares1.93M
TypeSH
Market value$183.30M
2.67%
Sole
1.93M
Shared
0.00
None
0.00
ALUMIS INC
SOLEShares6.35M
TypeSH
Market value$178.65M
2.60%
Sole
6.35M
Shared
0.00
None
0.00
IONIS PHARMACEUTICALS INC
SOLEShares2.20M
TypeSH
Market value$174.44M
2.54%
Sole
2.20M
Shared
0.00
None
0.00
COMPASS PATHWAYS PLC
SOLEShares12.16M
TypeSH
Market value$172.09M
2.50%
Sole
12.16M
Shared
0.00
None
0.00
VERA THERAPEUTICS INC
SOLEShares4M
TypeSH
Market value$171.64M
2.50%
Sole
4M
Shared
0.00
None
0.00
AXSOME THERAPEUTICS INC.
SOLEShares700K
TypeSH
Market value$171.34M
2.49%
Sole
700K
Shared
0.00
None
0.00
MOONLAKE IMMUNOTHERAPEUTICS
SOLEShares7M
TypeSH
Market value$136.27M
1.98%
Sole
7M
Shared
0.00
None
0.00
HEMAB THERAPEUTICS HLDGS INC
SOLEShares3.60M
TypeSH
Market value$132.30M
1.93%
Sole
3.60M
Shared
0.00
None
0.00
TANGO THERAPEUTICS INC
SOLEShares4.20M
TypeSH
Market value$131.29M
1.91%
Sole
4.20M
Shared
0.00
None
0.00
DEFINIUM THERAPEUTICS INC
SOLEShares2.75M
TypeSH
Market value$129.36M
1.88%
Sole
2.75M
Shared
0.00
None
0.00
GRAIL INC
SOLEShares1.83M
TypeSH
Market value$125.27M
1.82%
Sole
1.83M
Shared
0.00
None
0.00
BICARA THERAPEUTICS INC
SOLEShares4.10M
TypeSH
Market value$121.73M
1.77%
Sole
4.10M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
GUARDANT HEALTH INCSOLE | COM | 3.39M | SH | $509.10M 7.41% | 3.39M | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | COM | 9.34M | SH | $359.91M 5.24% | 9.34M | 0.00 | 0.00 |
STRUCTURE THERAPEUTICS INCSOLE | SPONSORED ADS | 4.74M | SH | $254.40M 3.70% | 4.74M | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 4.30M | SH | $249.96M 3.64% | 4.30M | 0.00 | 0.00 |
ALNYLAM PHARMACEUTICALS INCSOLE | COM | 825K | SH | $248.35M 3.61% | 825K | 0.00 | 0.00 |
VERADERMICS INCSOLE | COMMON STOCK | 2M | SH | $245.88M 3.58% | 2M | 0.00 | 0.00 |
GENMAB A/SSOLE | SPONSORED ADS | 8.65M | SH | $237.62M 3.46% | 8.65M | 0.00 | 0.00 |
TARSUS PHARMACEUTICALS INCSOLE | COM | 3.67M | SH | $230.79M 3.36% | 3.67M | 0.00 | 0.00 |
NUVALENT INCSOLE | COM | 1.78M | SH | $220.24M 3.21% | 1.78M | 0.00 | 0.00 |
ALKERMES PLCSOLE | SHS | 4M | SH | $209.58M 3.05% | 4M | 0.00 | 0.00 |
OCULAR THERAPEUTIX INCSOLE | COM | 19.69M | SH | $193.32M 2.81% | 19.69M | 0.00 | 0.00 |
BIOMARIN PHARMACEUTICAL INCSOLE | COM | 3.31M | SH | $189.25M 2.75% | 3.31M | 0.00 | 0.00 |
NURIX THERAPEUTICS INCSOLE | COM | 7.74M | SH | $187.69M 2.73% | 7.74M | 0.00 | 0.00 |
ORUKA THERAPEUTICS INCSOLE | COM | 1.93M | SH | $183.30M 2.67% | 1.93M | 0.00 | 0.00 |
ALUMIS INCSOLE | COM | 6.35M | SH | $178.65M 2.60% | 6.35M | 0.00 | 0.00 |
IONIS PHARMACEUTICALS INCSOLE | COM | 2.20M | SH | $174.44M 2.54% | 2.20M | 0.00 | 0.00 |
COMPASS PATHWAYS PLCSOLE | SPONSORED ADS | 12.16M | SH | $172.09M 2.50% | 12.16M | 0.00 | 0.00 |
VERA THERAPEUTICS INCSOLE | CL A | 4M | SH | $171.64M 2.50% | 4M | 0.00 | 0.00 |
AXSOME THERAPEUTICS INC.SOLE | COM | 700K | SH | $171.34M 2.49% | 700K | 0.00 | 0.00 |
MOONLAKE IMMUNOTHERAPEUTICSSOLE | CLASS A ORD | 7M | SH | $136.27M 1.98% | 7M | 0.00 | 0.00 |
HEMAB THERAPEUTICS HLDGS INCSOLE | COM SHS | 3.60M | SH | $132.30M 1.93% | 3.60M | 0.00 | 0.00 |
TANGO THERAPEUTICS INCSOLE | COM | 4.20M | SH | $131.29M 1.91% | 4.20M | 0.00 | 0.00 |
DEFINIUM THERAPEUTICS INCSOLE | COM SHS | 2.75M | SH | $129.36M 1.88% | 2.75M | 0.00 | 0.00 |
GRAIL INCSOLE | COM | 1.83M | SH | $125.27M 1.82% | 1.83M | 0.00 | 0.00 |
BICARA THERAPEUTICS INCSOLE | COM | 4.10M | SH | $121.73M 1.77% | 4.10M | 0.00 | 0.00 |
Page 1 of 3